These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2296352)

  • 21. Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency.
    Raja R; Bloom E; Johnson R; Goldstein M
    Adv Perit Dial; 1994; 10():135-8. PubMed ID: 7999811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperprolactinemia: a possible cause of sexual impotence in male patients undergoing chronic hemodialysis.
    Gura V; Weizman A; Maoz B; Zevin D; Ben-David M
    Nephron; 1980; 26(1):53-4. PubMed ID: 7393379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of erectile impotence in renal transplant patients with intracavernosal vasoactive drugs.
    Rodriguez Antolin A; Morales JM; Andrés A; Fernández Aparicio T; Díaz González R; Pamplona M; Alvarez E
    Transplant Proc; 1992 Feb; 24(1):105-6. PubMed ID: 1539195
    [No Abstract]   [Full Text] [Related]  

  • 24. Mechanisms and therapy of impotence associated with chronic renal failure and chronic dialysis.
    Krumlovsky FA; Madsen JD
    J Dial; 1979; 3(4):395-411. PubMed ID: 263961
    [No Abstract]   [Full Text] [Related]  

  • 25. Erythropoietin promotes erection recovery after nerve-sparing radical retropubic prostatectomy: a retrospective analysis.
    Burnett AL; Allaf ME; Bivalacqua TJ
    J Sex Med; 2008 Oct; 5(10):2392-8. PubMed ID: 18778310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical studies of recombinant human erythropoietin in patients on long-term dialysis].
    Ji SM; Li LS; Ji DX
    Zhonghua Nei Ke Za Zhi; 1993 Feb; 32(2):100-2. PubMed ID: 8404323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of recombinant human erythropoietin on hematological and hemostatic parameters with special reference to microhemolysis.
    Maurin N; Fitzner S; Fritz H; Gladziwa U; H agel J; Stefanidis I
    Clin Nephrol; 1995 Mar; 43(3):196-200. PubMed ID: 7774078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sexual potency of patients on chronic hemodialysis.
    Thurm J
    Urology; 1975 Jan; 5(1):60-2. PubMed ID: 1114547
    [No Abstract]   [Full Text] [Related]  

  • 29. [Erythropoietin--the first hematologic hormone in clinical use].
    Rhyner K
    Schweiz Med Wochenschr; 1988 Mar; 118(11):375-80. PubMed ID: 3287601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of blood pressure to increase following erythropoietin therapy in the renoprival status.
    De Santo NG; Manzo M; Raiola P; Lanzetti N; Capasso G; Ficociello R; Anastasio P; Esposito R
    Int J Artif Organs; 1992 Mar; 15(3):144-6. PubMed ID: 1521898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normalization of elevated prolactin levels in hemodialysis patients on erythropoietin.
    Schaefer RM; Kokot F; Kürner B; Zech M; Heidland A
    Nephron; 1988; 50(4):400-1. PubMed ID: 3237289
    [No Abstract]   [Full Text] [Related]  

  • 32. Improved sexual function in hemodialysis patients on recombinant erythropoietin: a possible role for prolactin.
    Schaefer RM; Kokot F; Wernze H; Geiger H; Heidland A
    Clin Nephrol; 1989 Jan; 31(1):1-5. PubMed ID: 2914405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensity of hemodialysis and response to erythropoietin.
    Uréna P; Pétrover M
    N Engl J Med; 1996 Jun; 334(25):1669; author reply 1670-1. PubMed ID: 8628368
    [No Abstract]   [Full Text] [Related]  

  • 34. [Usefulness of sildenafil in the treatment of erectile dysfunction in hemodialyzed men].
    Martín F; Reig A; Sarró F; Arenas MD; Ferrer R; González F; Gil MT; Egea J
    Nefrologia; 2001; 21(5):493-6. PubMed ID: 11795019
    [No Abstract]   [Full Text] [Related]  

  • 35. [Recombinant human erythropoietin (rh-EPO) in chronic, dialysis-dependent renal failure: effects on macro- and microcirculation and hematologic parameters].
    Köhler M; Mörsdorf S; Jung F; Braun B; Waldhausen P; Pindur G; Weber U; Bosslet R; Bambauer R; Jutzler GA
    Beitr Infusionsther; 1990; 26():89-95. PubMed ID: 1703909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anemia and blood pressure correction obtained by daily hemodialysis induce a reduction of left ventricular hypertrophy in dialysed patients.
    Fagugli RM; Buoncristiani U; Ciao G
    Int J Artif Organs; 1998 Jul; 21(7):429-31. PubMed ID: 9746000
    [No Abstract]   [Full Text] [Related]  

  • 37. The clinical effects of recombinant human erythropoietin for the treatment of anemia in end stage renal disease patients on dialysis.
    Uthayanaka Y; Jirajan B; Krairithichai U; Jantavanich N
    Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):577-82. PubMed ID: 8160072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The recovery of erythropoiesis after the short-term Recormon treatment of renal anemia].
    Nikolaev AIu; Klepikov PV; Lashutin SV
    Ter Arkh; 1992; 64(6):90-1. PubMed ID: 1440349
    [No Abstract]   [Full Text] [Related]  

  • 39. [Sexual dysfunction in males in long-term hemodialysis].
    Etcheverry M; Tignol J
    Acta Urol Belg; 1989; 57(1):207-12. PubMed ID: 2718842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation between blood pressure and hematocrit in anephric patients treated by means of recombinant DNA human erythropoietin.
    Iorio L; Saltarelli G; Nacca RG; Violi F
    Nephron; 1996; 72(2):373-4. PubMed ID: 8684581
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.